PAC Fixed Dose: Pharmacokinetics of a 1-Hour Paclitaxel Infusion and Comparison to BSA-Normalized Drug Dosing

By  

Oncology Research and Treatment, Vol. 29, Iss. 10, 2006-09 ,pp. : 444-450

Karger

Access to resources Recommend Favorite

Paclitaxel by 72-Hour Continuous Infusion Followed by Bolus Intravenous Ifosfamide or Epirubicin: Results of Two Phase I Studies

By  

Oncology, Vol. 60, Iss. 2, 2001-02 ,pp. : 116-122

Karger

Access to resources Recommend Favorite

Stenting and Adjunctive Delivery of Paclitaxel Via Balloon Coating Versus Durable Polymeric Matrix for De Novo Coronary Lesions: Clinical and Angiographic Results from the Prospective Randomized Trial

By  

JOURNAL OF INTERVENTIONAL CARDIOLOGY, Vol. 28, Iss. 4, 2015-08 ,pp. : 348-357

John Wiley & Sons Inc

Access to resources Recommend Favorite

Palonosetron in combination with 1‐day versus 3‐day dexamethasone for prevention of nausea and vomiting following paclitaxel and carboplatin in patients with gynecologic cancers: A randomized, multicenter, phase‐II trial

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 41, Iss. 10, 2015-10 ,pp. : 1607-1613

John Wiley & Sons Inc

Access to resources Recommend Favorite

Palonosetron in combination with 1‐day versus 3‐day dexamethasone for prevention of nausea and vomiting following paclitaxel and carboplatin in patients with gynecologic cancers: A randomized, multicenter, phase‐II trial

By  

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (ELECTRONIC), Vol. 1341-8076, Iss. 10, 2015-10 ,pp. : 1607-1613

John Wiley & Sons Inc

Access to resources Recommend Favorite